Journal of Cancer Prevention 2019; 24(2): 65-71
Published online June 30, 2019
© Korean Society of Cancer Prevention
1Department of Health Sciences and Technology, Graduate School of Medicine, Gachon University, 2Department of Biochemistry, College of Medicine, Gachon University, Incheon, Korea
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Peroxiredoxins (Prxs) are antioxidant enzymes that protect cells from oxidative stress by reducing intracellular accumulation of reactive oxygen species (ROS). In mammalian cells, the six Prx isoforms are ubiquitously expressed in diverse intracellular locations. They are involved in the regulation of various physiological processes including cell growth, differentiation, apoptosis, immune response and metabolism as well as intracellular ROS homeostasis. Although there are increasing evidences that Prxs are involved in carcinogenesis of many cancers, their role in cancer is controversial. The ROS levels in cancer cells are increased compared to normal cells, thus promoting cancer development. Nevertheless, for various cancer types, an overexpression of Prxs has been found to be associated with poor patient prognosis, and an increasing number of studies have reported that tumorigenesis is either facilitated or inhibited by regulation of cancer-associated signaling pathways. This review summarizes Prx isoforms and their basic functions, the relationship between the expression level and the physiological role of Prxs in cancer cells, and their roles in regulating cancer-associated signaling pathways.
Keywords: Peroxiredoxins, Oxidative stress, Cancer, Peroxidase activity, Tumorigenesis
Ho Hee JangJ Cancer Prev 2018; 23(4): 153-161 https://doi.org/10.15430/JCP.2018.23.4.153
Okezie I Aruoma, Kyung-Sun Kang, Theeshan Bahorun, Mi-Kyung Sung, Irfan RahmanCancer prevention research 2005; 10(3): 149-158
Kiyoon Kim*, Kwon Jeong* and Wonchae ChoeCancer prevention research 2010; 15(2): 101-105